Validation of Cognitive Enhancement Techniques for Mild Traumatic Brain Injury
NCT ID: NCT04245124
Last Updated: 2021-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
162 participants
INTERVENTIONAL
2021-02-01
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Cognitive Rehabilitation (CR) for severe brain injury focuses on compensatory strategies for activities of daily living such as using lists to remember grocery items or reminders to take medications and attend medical appointments. Research has shown CR interventions to have considerable effectiveness in the acute and sub-acute phase of recovery after severe TBI. But there is insufficient evidence that they improve rates of individuals returning to work, independence in activities of daily living (ADL), community re-integration, or quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Training to Enhance Frontal Lobe Reasoning
NCT01552473
Executive Function Training Intervention for Chronic Traumatic Brain Injury
NCT03704116
Rehabilitation of Traumatic Brain Injury in Active Duty Military Personnel and Veterans
NCT00540020
Mild TBI Assessment & Rehabilitation
NCT02920788
The Study of Cognitive Rehabilitation Effectiveness for Mild Traumatic Brain Injury
NCT01339806
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Generalizability from civilian and veteran communities to active duty SMs may pose some unique and unexplored factors as the goal of treatment is not remediation of common activities of daily living (e.g., remembering appointments) but in contrast, the goal is military readiness needed for worldwide deployability to potential wartime environments (e.g., "cognitive readiness").
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SMART INTERVENTION
N= 81 20 HOURS THERAPY IMMEDIATE POST TREATMENT EVALUATION 3 MONTH POST TREATMENT EVALUATION
Strategic Memory Advanced Reasoning Training
SMART focuses on three metacognitive strategies: Strategic Attention, Integrated Reasoning and Innovation.
TCR
N= 81 60 HOURS THERAPY IMMEDIATE POST TREATMENT EVALUATION 3 MONTH POST TREATMENT EVALUATION
Traditional Cognitive Rehabilitation
Participants randomized to the TCR condition will participate in a clinician-directed intervention that provides manualized, traditional clinician-directed cognitive rehabilitation that was developed for the SCORE trial (Cooper et al., 2017)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strategic Memory Advanced Reasoning Training
SMART focuses on three metacognitive strategies: Strategic Attention, Integrated Reasoning and Innovation.
Traditional Cognitive Rehabilitation
Participants randomized to the TCR condition will participate in a clinician-directed intervention that provides manualized, traditional clinician-directed cognitive rehabilitation that was developed for the SCORE trial (Cooper et al., 2017)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active duty military personnel
* History of mTBI: participants will have a history of at least one mTBI sustained \>3 months previously based on criteria of the DoD diagnostic criteria (Department of Veterans Affairs and Department of Defense, 2016). This specifies an external force to the head which resulted in physiological dysfunction of the brain as manifested by one or more of the following acute symptoms:
1. Any loss of consciousness (not to exceed 30 minutes)
2. Any loss of memory for the events immediately before or after the injury (not to exceed 1 day)
3. Any alteration of consciousness or change in mental state (not to exceed 24 hours)
* Persistent Post-Concussive Symptoms: Participants will endorse elevated neurobehavioral symptomatology compared to published normative data (Soble et al. 2014), with at least one cognitive symptom (e.g., a score of 3 or greater on at least one of the four items on the NSI cognitive domain).
Exclusion Criteria
* History of moderate, severe, or penetrating TBI as defined by DOD/VA guidelines during their lifetime
* Current substance use disorder based on patient self-report.
* History of a neurological disease other than mild TBI such as multiple sclerosis, cerebral vascular accident, brain tumor, neurodegenerative disease, or neuro-motor disorder.
* Current, active suicidal or homicidal ideation.
* Impaired decision-making capacity.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Texas at Dallas
OTHER
The Defense and Veterans Brain Injury Center
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naval Hospital Camp Pendleton
Oceanside, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NHCP.2020.0006
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.